UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006668
Receipt No. R000007875
Scientific Title A phase II study of modified XP therapy as first line chemotherapy for HER2 negative patient with unresectable or recurrent gastric cancer.
Date of disclosure of the study information 2011/11/04
Last modified on 2017/01/13 13:58:02

No. Disposal Last modified on Item of update
1 Insert 2011/11/04 11:38:22
2 Update 2012/02/01 08:49:00 Category of Funding Organization
Institutions
3 Update 2012/06/01 11:54:42 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
4 Update 2012/07/13 14:23:49 Institutions
5 Update 2012/11/06 10:10:26 Email
Email
Email1
Institutions
6 Update 2012/12/04 14:47:15 Institutions
7 Update 2013/05/08 11:42:50 Institutions
8 Update 2013/08/14 15:43:32 UMIN ID1
9 Update 2013/11/05 09:08:28 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
TEL
Email
10 Update 2014/05/07 21:17:33 Last name of contact person
Last name of contact person
Email
11 Update 2014/11/04 11:21:53 Recruitment status
12 Update 2015/05/07 09:09:13 Results
13 Update 2015/05/22 08:09:35 Email
Email
Email
Email1
14 Update 2016/02/24 19:12:23 Acronym
Acronym
15 Update 2016/05/06 12:31:50 Name of primary sponsor
Organization
16 Update 2017/01/13 13:51:31 Public title
17 Update 2017/01/13 13:58:02 Recruitment status
Publication of results
URL related to results and publications
Results


Contact us.